Results 111 to 120 of about 2,402,468 (250)
Clinical Toxicology, 2020 Medications for opioid use disorder (MOUD) including buprenorphine is recommended for patients with opioid use disorders. We sought to evaluate the frequencies of respiratory depression, intubation, and naloxone administration, and clinical outcomes among patients reported to the National Poison Database System (NPDS) following single-substance and ...
Michael A. Darracq, Stephen L. Thornton
openaire +3 more sources
Discovering Opioid Use Patterns from Social Media for Relapse Prevention [PDF]
arXiv, 2019 The United States is currently experiencing an unprecedented opioid crisis, and opioid overdose has become a leading cause of injury and death. Effective opioid addiction recovery calls for not only medical treatments, but also behavioral interventions for impacted individuals.
arxiv
Journal of Advanced Nursing, Volume 81, Issue 3, Page 1276-1285, March 2025.ABSTRACT Aim To present a comprehensive analysis of the Opioid‐Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023, evaluating its alignment with Russell and Fawcett's conceptual model of nursing and health policy and highlighting the implications for nursing practice and policy.
Evans F. Kyei +2 more
wiley +1 more source
Addiction Science & Clinical PracticeBackground Hospitalizations involving opioid use disorder (OUD) are increasing. Addiction consultation services (ACS) initiate medications for opioid use disorder (MOUD) in hospital settings and arrange post-hospital follow-up for ongoing MOUD care ...
Gavin Bart +11 more
doaj +1 more source
Journal of Hospital Medicine, Volume 20, Issue 2, Page 146-154, February 2025.Abstract Background Patient‐initiated or “before medically advised” (BMA) hospital discharge is more common among people who use drugs. Transitions of care can be destabilizing and might increase the risk of subsequent illicit drug overdose. Objectives This study sought to evaluate whether BMA discharge is associated with an increased risk of ...
John A. Staples +11 more
wiley +1 more source
Health Services Research, Volume 60, Issue 1, February 2025.Abstract Objective To determine how the rise of telehealth during the COVID‐19 pandemic impacted Medicaid enrollees' access to opioid use disorder (OUD) treatment. Data Sources and Study Setting Electronic health records from Northwestern Medicine, a large midwestern academic health system, from January 1, 2019 to December 31, 2021.
Lindsay D. Allen, Melinda Xu
wiley +1 more source
Understanding Polarizing Community Perspectives on Harm Reduction Strategies: Challenges to Addressing the Opioid Crisis in Appalachian Pennsylvania [PDF]
, 2021 Introduction: Rural communities face barriers to opioid treatment and overdose prevention including concerns about stigma and lack of harm reduction services.
Burke, Jessica G, PhD +3 more
core +1 more source
Background:Non-prescribed opioid use is illegal in Vietnam. People who are apprehended for use of non-prescribed opioids may be arrested and incarcerated or sent to compulsory rehabilitation centers.
core +3 more sources
Addiction, Volume 120, Issue 2, Page 236-250, February 2025.Abstract Aims This study aimed to estimate the strength of association between prescriptions of glucose‐dependent insulinotropic polypeptide (GIP) and/or glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and the incidence of opioid overdose and alcohol intoxication in patients with opioid use disorder (OUD) and alcohol use disorder (AUD ...
Fares Qeadan +2 more
wiley +1 more source
Medication for Opioid Use Disorder in a Community Mental Health Clinic [PDF]
Background: Over 100,000 people died from opioid-related overdoses in the United States in 2023. People experiencing homelessness (PEH) are at especially high risk of co-occurring mental illness and substance use disorder, and face added barriers to ...
Magness, Hannah
core +1 more source